BioSpace News Archive

The Baltimore Longitudinal Study of Aging was launched in 1958 by the National Institutes of Health. The idea was to follow and study the lives of healthy, active people over their lifetimes, rather than after they were dead.

MAPS is testing MDMA in a Phase III trial and hopes to seek regulatory approval by 2021.

Acquisition adds clinical-stage anti-FcRn antibody SYNT001 to company’s growing pipeline

The CNS Summit has announced the 2018 CNS Summit Innovation Index, which ranks life science companies based on publicly available information, with regards to three facets of innovation: Trial Optimization, Digital Advancement, and Innovative Partnerships.

Birner Dental Management Services, Inc. (OTCQX: BDMS), business services provider of PERFECT TEETH™ dental practices, will conduct a conference call to review third quarter and nine month 2018 results.

Across every clinical trial, Pharma and Biotech have a dire need to access patients in efficient numbers and to conduct their study to the highest quality possible.

Technavio analysts forecast the global animal vaccines market to grow at a CAGR of close to 5% during the forecast period, according to their latest market research report.

In a decision released yesterday, the Federal Court of Appeal certified a class proceeding on behalf of forgotten Thalidomide Survivors who were rejected by the Thalidomide Survivors Contribution Program (TSCP), a Federal Government program designed to provide monetary support to the aging survivors of this terrible tragedy.

Hospitals and health systems at the forefront of using healthcare IT to improve the delivery of care have maximized the benefits of foundational technologies and are embracing new technologies that support population management and value-based care.

Partnership improves access to great dermatologic care